Findings from Fudan University in Monoclonal Antibodies Provides New Insights (A Randomized, Double-Blind, Parallel-Group, Phase 1 Clinical Trial Comparing the Pharmacokinetic, Safety, and Immunogenicity of the Biosimilar HS016 and the ...)

Source :: Immunotherapy Weekly. June 10, 2020, 837
Publication Year :: 2020
Abstract: 2020 JUN 10 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Researchers detail new data in Drugs and Therapies - Monoclonal Antibodies. According to news reporting [...]

Subjects :: Clinical trials -- Research
Immunotherapy -- Research
Biological products -- Product development
Adalimumab -- Research -- Product development
Monoclonal antibodies
Antibodies
Drugs
Editors
Health
Fudan University

Tools